期刊文献+

同种异体骨椎间融合器的研究进展及临床应用现状 被引量:7

PROGRESS AND CLINICAL APPLICATION OF ALLOGRAFT BONE SPACER IN CERVICAL AND LUMBAR INTERBODY FUSION
原文传递
导出
摘要 目的对同种异体骨椎间融合器的研究进展和临床应用现状进行综述。方法查阅国内外采用同种异体骨椎间融合器治疗颈腰椎退行性疾病的相关文献,分析其优缺点、术后融合率、临床疗效及并发症。结果同种异体骨椎间融合器的术后融合率、临床效果与自体骨、聚醚醚酮融合器相近,但其适应证、远期疗效及术后并发症等仍需继续观察。结论同种异体骨椎间融合器的最佳适应证和远期效果需进一步研究,以期为临床决策提供充足证据。 Objective To review the research progress and clinical application of allograft bone spacer in cervical and lumbar interbody fusion. Methods Literature about allograft bone spacer in cervical and lumbar degenerative disease was reviewed and analyzed, including the advantages and disadvantages of allograft material, fusion rate, effectiveness, and complications. Results Fusion rate and effectiveness ofallograft bone spacers were similar to those of autograft and polyetheretherketone spacers, and they were recommended by many orthopedists. However, indications, long-term effectiveness, and complications were not clear. Condusion Further study on allograft bone spacer in cervical and lumbar interbody fusion should be focused on optimal indications and long-term effectiveness.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2015年第3期381-385,共5页 Chinese Journal of Reparative and Reconstructive Surgery
基金 桂林市科学研究与技术开发计划(20140120-3-3)~~
关键词 同种异体骨 椎间融合术 椎间融合器 Allograft bone Interbody fusion Interbody spacer
  • 相关文献

参考文献2

二级参考文献50

  • 1吕宏琳,周跃,王建,郝勇.颈椎可吸收椎间融合器治疗颈椎病对其生理前凸及椎间隙高度和功能综合恢复指标的影响:23例半年随访[J].中国临床康复,2005,9(14):12-13. 被引量:5
  • 2郝勇,周跃,滕海军,曹国勇,潘勇.聚内消旋乳酸(PDLLA)椎间融合器在椎间降解情况的实验观察[J].中国矫形外科杂志,2006,14(3):206-208. 被引量:5
  • 3Smit TH, Engels TA, Wuisman PI, et al. Time-dependent mechanical strength of 70/30 Poly (L, DL-lactide): shedding light on the premature failure of degradable spinal cages. Spine (Phila Pa 1976), 2008, 33(1): 14-18.
  • 4Engels TA, Sontjens SH, Smit TH, et al. Time-dependent failure of amorphous polylactides in static loading conditions. J Mater Sci Mater Med, 2010, 21(1): 89-97.
  • 5Smit TH, Engels TA, Sontjens SH, et al. Time-dependent failure in load-bearing polymers: a potential hazard in structural applications of polylactides. J Mater Sci Mater Med, 2010, 21(3): 871-878.
  • 6Lowe TG, Coe JD. Bioresorbable polymer implants in the unilateral transforaminal lumbar interbody fusion procedure. Orthopedics, 2002, 25(10 Suppl): s1179-1183.
  • 7Coe JD. Instrumented transforaminal lumbar interbody fusion with bioabsorbable polymer implants and iliac crest autograft. Neurosurg Focus, 2004, 16(3): E11.
  • 8Coe JD, Vaccaro AR. Instrumented transforaminal lumbar interbody fusion with bioresorbable polymer implants and iliac crest autograft. Spine (Phila Pa 1976), 2005, 30(17 Suppl): S76-83.
  • 9Couture DE, Branch CL. Posterior lumbar interbody fusion with bio- absorbable spacers and local autograft in a series of 27 patients. Neurosurg Focus, 2004, 16(3): E8.
  • 10Lanman TH, Hopkins TJ. Lumbar interbody fusion after treatment with recombinant human bone morphogenetic protein-2 added to poly (L-lactide-co-D, L-lactide) bioresorbable implants. Neurosurg Focus, 2004, 16(3): E9.

共引文献7

同被引文献55

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部